Torrent Pharma Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Mar 22, 2024
  • 1 Class I recall
  • No warning letters matched by name
Inspections 3 0 OAI
Recalls 84 1 Class I (1%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Torrent Pharma Inc has 84 FDA recalls (1 Class I), 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Torrent Pharma Inc" is on file.

What these totals cover: FDA records filed under the name "Torrent Pharma Inc" and its spelling variant "Torrent Pharma".

Latest recall
D-0455-2025 · Class II · May 27, 2025
Latest inspection
Mar 22, 2024 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls84 (1 Class I)Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections3Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Torrent Pharma Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Torrent Pharma Inc: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 18 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 58 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 2 recall records (1 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500020
202410000
202300000
202200010
202100020
202000021
2019000580
2018000180
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Torrent Pharma Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Torrent Pharma Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

84 recall records from Jul 22, 2013 to May 27, 2025. Showing the 20 most recent. View all 84 recall records

NumberClassProductDate
D-0455-2025Class IIFluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS…May 27, 2025
D-0456-2025Class IIFluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT…May 27, 2025
D-0852-2022Class IIPantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle…Apr 11, 2022
D-0365-2022Class IICarbamazepine Tablets, USP 200 mg 100 Tablets Rx only NDC 13668-268-01 Manufactured by: Torrent…Dec 2, 2021
D-0285-2022Class IIITelmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only…Dec 1, 2021
D-0166-2021Class IAnagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma…Nov 25, 2020
D-1317-2020Class IICarbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent…May 11, 2020
D-0123-2020Class IILosartan Potassium /Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 tablets per bottle, Rx Only…Sep 19, 2019
D-0124-2020Class IILosartan Potassium/ Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 tablets per bottle, Rx Only…Sep 19, 2019
D-0121-2020Class IILosartan Potassium Tablets, USP 50mg, 1000 tablets per bottle, Rx Only, Manufactured for: Torrent…Sep 19, 2019
D-0122-2020Class IILosartan Potassium Tablets, USP 100 mg, [90 or 1000] tablets per bottle, Rx Only, Manufactured for…Sep 19, 2019
D-1862-2019Class IIAnagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only, Manufactured in India for: Torrent…Sep 6, 2019
D-1378-2019Class IIHemorrhoidal Suppositories (Phenylephrine HCl 0.25%; Hard Fat 88.7%), 12 Rectal Suppositories per…May 21, 2019
D-1345-2019Class IIRisperiDONE Oral Solution, USP, 1 mg/mL, Rx Only, 30 mL bottle, NDC 13668-589-06, Manufactured by…May 21, 2019
D-1360-2019Class IIHyoscyamine Sulfate Elixir 0.125 mg per 5 mL, Rx Only, 473 mL (16 oz.) bottle, NDC:39328-048-16…May 21, 2019
D-1369-2019Class IIExtra Action Cough Syrup (Guaifenesin and Dextromethorphan HBr Syrup) 100 mg/10 mg per 5 mL, a) 4…May 21, 2019
D-1368-2019Class IICough Syrup (Guaifenesin Syrup, USP) 200 mg/10 mL, Alcohol free Non-Narcotic Expectorant, One Pint…May 21, 2019
D-1361-2019Class IICetirizine HCL Oral Solution, USP 1mg/mL, 4 oz - BULK, PLDMay 21, 2019
D-1359-2019Class IIHyoscyamine Oral Drops 0.125 mg/mL, Rx Only, 15 mL bottle (0.5 FL. oz.), NDC: 39328-047-15, Manuf…May 21, 2019
D-1379-2019Class IIAnu-Med brand of Hemorrhoidal Suppositories (Phenylephrine HCl 0.25%; Hard Fat 88.7%), 12…May 21, 2019

Recent FDA inspections

3 inspections from Aug 24, 2011 to Mar 22, 2024.

DateSiteProductClassificationFEI
Mar 22, 2024Basking Ridge, NJDrugsNo Action Indicated (NAI)3010329515
Dec 12, 2014Kalamazoo, MIDrugsNo Action Indicated (NAI)3006441134
Aug 24, 2011Kalamazoo, MIDrugsNo Action Indicated (NAI)3006441134
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3010329515Basking Ridge, NJ1Mar 22, 2024
FEI 3006441134Kalamazoo, MI2Dec 12, 2014

Torrent Pharma Inc and the FDA: common questions

Has Torrent Pharma Inc received an FDA warning letter?

No FDA warning letter addressed to the name "Torrent Pharma Inc" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Torrent Pharma Inc received an FDA Form 483?

FDA has not published a Form 483 for "Torrent Pharma Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Torrent Pharma Inc?

The most recent FDA inspection on file ended Mar 22, 2024 at Basking Ridge, NJ and was classified NAI. FDA has 3 inspections of Torrent Pharma Inc on file.

Has Torrent Pharma Inc had an FDA recall?

Yes. Torrent Pharma Inc has 84 FDA recalls on record, 1 of them Class I, the most serious class. The most recent started May 27, 2025.

Need more than this page shows? Ask about Torrent Pharma Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.